Sarah Dye
As Vice President of Oncology and Specialty Pharmaceuticals with Optum’s Medical Benefit Management division, Sarah has responsibility for a comprehensive solution set that includes the Cancer and Specialty Guidance Programs. Sarah is passionate about these complicated conditions and how Optum can help ensure consumers receive quality care and support services to help them navigate a complicated system.
Sarah joined UnitedHealth Group in 2003 and held several other roles including leading Operations and Affordability with Optum International where she focused entirely on the Brazil health care market. Prior to Optum International, Sarah was Principal at UnitedHealth Group Ventures where she analyzed the market to identify new investment opportunities designed to create disruptive, positive change in the health care system.
Across her roles, Sarah uses her engineering training to perform root cause analysis to identify systemic issues in the health care and ultimately design new products to address these issues. She successfully developed and launched new products in oncology, women’s health and orthopedics.
Sarah holds a bachelor’s degree in industrial engineering from Iowa State University.
Joel Barthelemy
Devi Kyanam
Vijesh Unnikrishnan
Amanda Gorman
Cathy Seabag
